A phase 2 basket trial of tarlatamab in patients with advanced DLL3-expressing tumors: University of California Lung Cancer Consortium UCCC-01/UCLA L-10.

Authors: Michael Oh, Daniel P. Stefanko, Gregory A. Fishbein, Tianhong Li, Sandip Pravin Patel, Cathleen Park, Claire Mulvey, Joel R. Hecht, Edward B Garon, Amy Lauren Cummings, Aaron Lisberg, Zev A. Wainberg, Christine Kivork, Larissa Ikenouye, Jonathan W. Goldman

Published: 2025-05-28

DOI: 10.1200/jco.2025.43.16_suppl.tps2700

Source: Full article

---

Abstract

TPS2700